Mein Warenkorb

Glypican 2

Glypican 2 Molekülinformation

Englischer NameGlypican-2Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2Target-AliasCerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Englischer NameGlypican-2
Target-AliasCerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical

Glypican 2 Produktliste

  • Attribut

    Protein (7)

  • Produktbibliothek

    Online (7)

  • Spezies

    Human (4)Mouse (1)Rhesus macaque (2)

  • Etikett

    His Tag (3)Fc Tag (1)Llama IgG Fc Tag (1)His Tag & Avi Tag (2)

  • Marker

    Unconjugated (5)Biotin-labeled (2)

Glypican 2 Molekülhintergrund

Glypican 2 (GPC2), also known cerebroglycan, is a glycophosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found in the developing nervous system. Cerebroglycan participates in cell adhesion and is thought to regulate the growth and guidance of axons. Cerebroglycan has especially high affinity for laminin-1. GPC2 silencing inactivates Wnt/β-catenin signaling and reduces the expression of N-Myc, an oncogenic driver of neuroblastoma tumorigenesis. Immunotoxins and chimeric antigen receptor (CAR) T cells targeting GPC2 inhibit neuroblastoma growth in mouse models. A GPC3 specific antibody drug conjugate (ADC) can also inhibit neuroblastoma cell proliferation.

Glypican 2 Molekülalias

Glypican 2,GPC2

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma)Phase 1 ClinicalChildrens Hospital of PhiladelphiaRhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details
GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics)TmGPC2-01-CAR-TPhase 1 ClinicalChildrens Hospital of PhiladelphiaSmall Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns